The Role of Chronic Liver Diseases in the Emergence and Recurrence of Hepatocellular Carcinoma: An Omics Perspective.

Zanotti, Sofia; Boot, Gina F; Coto-Llerena, Mairene; Gallon, John; Hess, Gabriel F; Soysal, Savas D; Kollmar, Otto; Ng, Charlotte K Y; Piscuoglio, Salvatore (2022). The Role of Chronic Liver Diseases in the Emergence and Recurrence of Hepatocellular Carcinoma: An Omics Perspective. Frontiers in medicine, 9, p. 888850. Frontiers 10.3389/fmed.2022.888850

[img]
Preview
Text
fmed-09-888850.pdf - Published Version
Available under License Creative Commons: Attribution (CC-BY).

Download (1MB) | Preview

Hepatocellular carcinoma (HCC) typically develops from a background of cirrhosis resulting from chronic inflammation. This inflammation is frequently associated with chronic liver diseases (CLD). The advent of next generation sequencing has enabled extensive analyses of molecular aberrations in HCC. However, less attention has been directed to the chronically inflamed background of the liver, prior to HCC emergence and during recurrence following surgery. Hepatocytes within chronically inflamed liver tissues present highly activated inflammatory signaling pathways and accumulation of a complex mutational landscape. In this altered environment, cells may transform in a stepwise manner toward tumorigenesis. Similarly, the chronically inflamed environment which persists after resection may impact the timing of HCC recurrence. Advances in research are allowing an extensive epigenomic, transcriptomic and proteomic characterization of CLD which define the emergence of HCC or its recurrence. The amount of data generated will enable the understanding of oncogenic mechanisms in HCC from the CLD perspective and provide the possibility to identify robust biomarkers or novel therapeutic targets for the treatment of primary and recurrent HCC. Importantly, biomarkers defined by the analysis of CLD tissue may permit the early detection or prevention of HCC emergence and recurrence. In this review, we compile the current omics based evidence of the contribution of CLD tissues to the emergence and recurrence of HCC.

Item Type:

Journal Article (Review Article)

Division/Institute:

04 Faculty of Medicine > Pre-clinic Human Medicine > BioMedical Research (DBMR)

UniBE Contributor:

Ng, Kiu Yan Charlotte

Subjects:

600 Technology > 610 Medicine & health

ISSN:

2296-858X

Publisher:

Frontiers

Language:

English

Submitter:

Pubmed Import

Date Deposited:

12 Jul 2022 14:41

Last Modified:

05 Dec 2022 16:21

Publisher DOI:

10.3389/fmed.2022.888850

PubMed ID:

35814741

Uncontrolled Keywords:

chronic liver disease epigenetics genomics hepatocellular carcinoma metabolomics proteomics transcriptomics

BORIS DOI:

10.48350/171261

URI:

https://boris.unibe.ch/id/eprint/171261

Actions (login required)

Edit item Edit item
Provide Feedback